Founders / Sally Daub
Sally Daub
Sally Daub is the co-founder and president of Altis Labs, a health and biotech AI company based in Toronto. Sally Daub co-founded Altis Labs with Felix Baldauf-Lenschen. Altis Labs had raised US$31M across 2 rounds as of November 2026, most recently a US$25M Series A in September 2026 led by OrbiMed and Qiming Venture Partners USA. The Canadian AI Newsletter last covered Altis Labs in September 2026.
Co-founder/President of Altis Labs.
Altis Labs
AI endpoints for oncology trials; IPRO model predicts survival from routine radiology scans (Nota platform).
- Role
- Co-founder/President
- HQ
- Toronto, ON
- Founded
- 2019
- Status
- Active
- Disclosed raised
- US$31M
- Latest round
- Series A, Sep 17, 2026
- Website
- altislabs.com
Co-founders: Felix Baldauf-Lenschen
Investors: OrbiMed, Qiming Venture Partners USA, Benchstrength, Debiopharm Innovation Fund, Innovation Endeavors, Fusion Fund, Lumira Ventures
In the newsletter
Founders are listed as named in primary coverage of their companies. Profile links are matched to the company before they are published. To correct this page or ask for it to be removed, email the Index.
Data as of November 10, 2026.